Hält derzeit eine Position bei Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Innovation Officer | Apellis Pharmaceuticals Inc | 1. April 2019 - |
Executive Vice President - Research and Development | Apellis Pharmaceuticals Inc | 1. April 2018 - 1. April 2019 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-09-07 | 2023-09-06 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
1.756
-2.5%
43,0175.526 USD |
1.756 -2.5% | 43,01 | 75.526 USD | |
2022-05-31 | 2022-05-27 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
10.000
-19.9%
43,00430.000 USD |
10.000 -19.9% | 43,00 | 430.000 USD | |
2022-04-06 | 2022-04-05 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
609
-1.2%
60,0936.593 USD |
609 -1.2% | 60,09 | 36.593 USD | |
2022-04-05 | 2022-04-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
1.249
-2.3%
57,8172.198 USD |
1.249 -2.3% | 57,81 | 72.198 USD | |
2022-04-05 | 2022-04-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
1.437
-2.6%
56,8681.714 USD |
1.437 -2.6% | 56,86 | 81.714 USD | |
2022-04-05 | 2022-04-04 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
818
-1.5%
55,8445.677 USD |
818 -1.5% | 55,84 | 45.677 USD | |
2022-04-04 | 2022-04-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
11.496
-18.0%
55,05632.855 USD |
11.496 -18.0% | 55,05 | 632.855 USD | |
2022-02-14 | 2022-02-11 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
1.666
-3.1%
46,8077.969 USD |
1.666 -3.1% | 46,80 | 77.969 USD | |
2022-02-14 | 2022-02-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
10.000
-15.8%
50,00500.000 USD |
10.000 -15.8% | 50,00 | 500.000 USD | |
2022-02-10 | 2022-02-08 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
10.000
-15.7%
45,00450.000 USD |
10.000 -15.7% | 45,00 | 450.000 USD | |
2022-02-01 | 2022-01-31 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
1.233
-2.2%
38,4747.434 USD |
1.233 -2.2% | 38,47 | 47.434 USD | |
2021-06-11 | 2021-06-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
3.417
-11.4%
60,00205.020 USD |
3.417 -11.4% | 60,00 | 205.020 USD |